FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Bart Sangal

Research Profile

Disorders

Physiology

Procedures

Chemicals & Drugs

Concepts & Ideas

Reaction Time

Co-author Network

Publications

TOP 3
R Bart Sangal
Evaluating sleepiness-related daytime function by querying wakefulness inability and fatigue: Sleepiness-Wakefulness Inability and Fatigue Test (SWIFT).
Earle E Bain; Dawnelle L McNeill; Weining Z Robieson; Walid Abi-Saab; George Apostol; R Bart Sangal; Mario Saltarelli
A randomized pilot study of the efficacy and safety of ABT-089, a novel α4β2 neuronal nicotinic receptor agonist, in adults with attention-deficit/hyperactivity disorder.
M Soriano-Co; Thomas E Vanhecke; Barry A Franklin; B Hakmeh; R Bart Sangal; P A McCullough
Increased central adiposity in morbidly obese patients with obstructive sleep apnoea.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Bart Sangal (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: R Bart Sangal
Evaluating sleepiness-related daytime function by querying wakefulness inability and fatigue: Sleepiness-Wakefulness Inability and Fatigue Test (SWIFT).
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2012;8(6):701-11.
2012: Earle E Bain; Dawnelle L McNeill; Weining Z Robieson; Walid Abi-Saab; George Apostol; R Bart Sangal; Mario Saltarelli
A randomized pilot study of the efficacy and safety of ABT-089, a novel α4β2 neuronal nicotinic receptor agonist, in adults with attention-deficit/hyperactivity disorder.
The Journal of clinical psychiatry 2012;73(6):783-9.
2011: M Soriano-Co; Thomas E Vanhecke; Barry A Franklin; B Hakmeh; R Bart Sangal; P A McCullough
Increased central adiposity in morbidly obese patients with obstructive sleep apnoea.
Internal medicine journal 2011;41(7):560-6.
2009: Judith Owens; R Bart Sangal; Virginia K Sutton; Rosalie Bakken; Albert J Allen; Douglas Kelsey
Subjective and objective measures of sleep in children with attention-deficit/hyperactivity disorder.
Sleep medicine 2009;10(4):446-56.
2009: Varun Agrawal; Thomas E Vanhecke; Baroon Rai; Barry A Franklin; R Bart Sangal; Peter A McCullough
Albuminuria and renal function in obese adults evaluated for obstructive sleep apnea.
Nephron. Clinical practice 2009;113(3):c140-7.
2008: Thomas E Vanhecke; Barry A Franklin; Kerstyn C Zalesin; R Bart Sangal; Adam T Dejong; Varun Agrawal; Peter A McCullough
Cardiorespiratory fitness and obstructive sleep apnea syndrome in morbidly obese patients.
Chest 2008;134(3):539-45.
2008: Thomas E Vanhecke; Barry A Franklin; Steven C Ajluni; R Bart Sangal; Peter A McCullough
Cardiorespiratory fitness and sleep-related breathing disorders.
Expert review of cardiovascular therapy 2008;6(5):745-58.
2007: Thomas J Spencer; Christopher J Kratochvil; R Bart Sangal; Keith E Saylor; Charles E Bailey; David W Dunn; Daniel A Geller; Charles D Casat; Robert S Lipetz; Rakesh Jain; Jeffrey H Newcorn; Dustin D Ruff; Peter Feldman; Amanda J Furr; Albert J Allen
Effects of atomoxetine on growth in children with attention-deficit/hyperactivity disorder following up to five years of treatment.
Journal of child and adolescent psychopharmacology 2007;17(5):689-700.
2006: R Bart Sangal; Judith Owens; Albert J Allen; Virginia K Sutton; Kory J Schuh; Douglas Kelsey
Effects of atomoxetine and methylphenidate on sleep in children with ADHD.
Sleep 2006;29(12):1573-85.
2006: Lenard A Adler; Virginia K Sutton; Rodney J Moore; Anthony P Dietrich; Frederick W Reimherr; R Bart Sangal; Keith E Saylor; Kristina Secnik; Douglas Kelsey; Albert J Allen
Quality of life assessment in adult patients with attention-deficit/hyperactivity disorder treated with atomoxetine.
Journal of clinical psychopharmacology 2006;26(6):648-52.
2006: R Bart Sangal; JoAnne M Sangal
Attention-deficit/hyperactivity disorder: using P300 topography to choose optimal treatment.
Expert review of neurotherapeutics 2006;6(10):1429-37.
2006: R Bart Sangal; JoAnne M Sangal
Attention-deficit/hyperactivity disorder: use of cognitive evoked potential (P300) to predict treatment response.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2006;117(9):1996-2006.
2006: R Bart Sangal
When is sleepiness a disease? How do we measure it?
Sleep medicine 2006;7(4):310-1.
2006: Laurence L Greenhill; Joseph Biederman; Samuel W Boellner; Thomas A Rugino; R Bart Sangal; Craig Q Earl; John G Jiang; James M Swanson
A randomized, double-blind, placebo-controlled study of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder.
Journal of the American Academy of Child and Adolescent Psychiatry 2006;45(5):503-11.
2005: R Bart Sangal; Judith A Owens; JoAnne M Sangal
Patients with attention-deficit/hyperactivity disorder without observed apneic episodes in sleep or daytime sleepiness have normal sleep on polysomnography.
Sleep 2005;28(9):1143-8.
2005: R Bart Sangal; JoAnne M Sangal
Attention-deficit/hyperactivity disorder: cognitive evoked potential (P300) amplitude predicts treatment response to atomoxetine.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2005;116(3):640-7.
2005: Donna Arand; Michael Bonnet; Thomas Hurwitz; Merrill M. Mitler; Roger Rosa; R Bart Sangal
The clinical use of the MSLT and MWT.
Sleep 2005;28(1):123-44.
2004: Sharon B Wigal; James M Swanson; David Feifel; R Bart Sangal; Josephine Elia; Charles D Casat; Jerome B Zeldis; C Keith Conners
A double-blind, placebo-controlled trial of dexmethylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in children with attention-deficit/hyperactivity disorder.
Journal of the American Academy of Child and Adolescent Psychiatry 2004;43(11):1406-14.
2004: R Bart Sangal; JoAnne M Sangal
Rating scales for inattention and sleepiness are correlated in adults with symptoms of sleep disordered breathing syndrome, but not in adults with symptoms of attention-deficit/hyperactivity disorder.
Sleep medicine 2004;5(2):133-5.
2004: L Eugene Arnold; Ronald L Lindsay; C Keith Conners; Sharon B Wigal; Alan J Levine; Diane E Johnson; Scott A West; R Bart Sangal; Timothy P Bohan; Jerome B Zeldis
A double-blind, placebo-controlled withdrawal trial of dexmethylphenidate hydrochloride in children with attention deficit hyperactivity disorder.
Journal of child and adolescent psychopharmacology 2004;14(4):542-54.
2004: R Bart Sangal; JoAnne M Sangal
Attention-deficit/hyperactivity disorder: cognitive evoked potential (P300) topography predicts treatment response to methylphenidate.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2004;115(1):188-93.
2003: R Bart Sangal; JoAnne M Sangal
What is a significant response in drug studies of attention-deficit/hyperactivity disorder: statistical significance is necessary, but is it sufficient?
Psychopharmacology bulletin 2003;37(2):50-8.
2002: David Michelson; Albert J Allen; Joan Busner; Charles D Casat; David Dunn; Christopher J Kratochvil; Jeffrey H Newcorn; Floyd R Sallee; R Bart Sangal; Keith E Saylor; Scott West; Douglas Kelsey; Joachim F Wernicke; Nancy J Trapp; Donald Harder
Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study.
The American journal of psychiatry 2002;159(11):1896-901.
1999: R Bart Sangal; Merrill M. Mitler; JoAnne M Sangal
Subjective sleepiness ratings (Epworth sleepiness scale) do not reflect the same parameter of sleepiness as objective sleepiness (maintenance of wakefulness test) in patients with narcolepsy.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 1999;110(12):2131-5.
1999: R Bart Sangal; JoAnne M Sangal; CL Belisle
Visual P300 latency predicts treatment response to modafinil in patients with narcolepsy.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 1999;110(6):1041-7.
1999: R Bart Sangal; JoAnne M Sangal; CL Belisle
Subjective and objective indices of sleepiness (ESS and MWT) are not equally useful in patients with sleep apnea.
Clinical EEG (electroencephalography) 1999;30(2):73-5.
1999: R Bart Sangal; JoAnne M Sangal; CL Belisle
Longer auditory and visual P300 latencies in patients with narcolepsy.
Clinical EEG (electroencephalography) 1999;30(1):28-32.
1998: Merrill M. Mitler; Joyce A Walsleben; R Bart Sangal; M Hirshkowitz
Sleep latency on the maintenance of wakefulness test (MWT) for 530 patients with narcolepsy while free of psychoactive drugs.
Electroencephalography and clinical neurophysiology 1998;107(1):33-8.
1998: R Bart Sangal; JoAnne M Sangal; CL Belisle
P300 latency and age: a quadratic regression explains their relationship from age 5 to 85.
Clinical EEG (electroencephalography) 1998;29(1):1-6.
1997: Karl Doghramji; Merrill M. Mitler; R Bart Sangal; C Shapiro; S Taylor; Joyce A Walsleben; CL Belisle; M K Erman; Roza Hayduk; R Hosn; E B O'Malley; JoAnne M Sangal; SL Schutte; James Youakim
A normative study of the maintenance of wakefulness test (MWT).
Electroencephalography and clinical neurophysiology 1997;103(5):554-62.
1997: R Bart Sangal; JoAnne M Sangal
Abnormal visual P300 latency in obstructive sleep apnea does not change acutely upon treatment with CPAP.
Sleep 1997;20(9):702-4.
1997: R Bart Sangal; JoAnne M Sangal
Measurement of P300 and sleep characteristics in patients with hypersomnia: do P300 latencies, P300 amplitudes, and multiple sleep latency and maintenance of wakefulness tests measure different factors?
Clinical EEG (electroencephalography) 1997;28(3):179-84.
1997: R Bart Sangal; JoAnne M Sangal
Obstructive sleep apnea and abnormal P300 latency topography.
Clinical EEG (electroencephalography) 1997;28(1):16-25.
1996: JoAnne M Sangal; R Bart Sangal; B Persky
Prolonged P300 latency in attention deficit hyperactivity disorder predicts poor response to imipramine.
Clinical EEG (electroencephalography) 1996;27(4):191-201.
1996: R Bart Sangal; JoAnne M Sangal
Closed head injury patients with mild cognitive complaints without neurological or psychiatric findings have abnormal visual P300 latencies.
Biological psychiatry 1996;39(4):305-7.
1996: R Bart Sangal; JoAnne M Sangal
Topography of auditory and visual P300 in normal children.
Clinical EEG (electroencephalography) 1996;27(1):46-51.
1995: JoAnne M Sangal; R Bart Sangal; B Persky
Abnormal auditory P300 topography in attention deficit disorder predicts poor response to pemoline.
Clinical EEG (electroencephalography) 1995;26(4):204-13.
1995: R Bart Sangal; JoAnne M Sangal
P300 latency: abnormal in sleep apnea with somnolence and idiopathic hypersomnia, but normal in narcolepsy.
Clinical EEG (electroencephalography) 1995;26(3):146-53.
1992: R Bart Sangal; L Thomas; Merrill M. Mitler
Disorders of excessive sleepiness. Treatment improves ability to stay awake but does not reduce sleepiness.
Chest 1992;102(3):699-703.
1992: R Bart Sangal; L Thomas; Merrill M. Mitler
Maintenance of wakefulness test and multiple sleep latency test. Measurement of different abilities in patients with sleep disorders.
Chest 1992;101(4):898-902.